Theodore R Levin, Christopher D Jensen, Natalia Udaltsova, Andrea A Burnett-Hartman, Aruna Kamineni, Chun R Chao, Joanne E Schottinger, Nirupa R Ghai, Gaia Pocobelli, Larissa L White, Malia Oliver, Hina Chowdhry, Brian P Hixon, Jessica M Badalov, Shauna R Goldberg, Susan C Bradford, Charles P Quesenberry, Jeffrey K Lee
{"title":"Colorectal Cancer Screening Completion and Yield in Patients Aged 45 to 50 Years : An Observational Study.","authors":"Theodore R Levin, Christopher D Jensen, Natalia Udaltsova, Andrea A Burnett-Hartman, Aruna Kamineni, Chun R Chao, Joanne E Schottinger, Nirupa R Ghai, Gaia Pocobelli, Larissa L White, Malia Oliver, Hina Chowdhry, Brian P Hixon, Jessica M Badalov, Shauna R Goldberg, Susan C Bradford, Charles P Quesenberry, Jeffrey K Lee","doi":"10.7326/M24-0743","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Guidelines now recommend initiating colorectal cancer (CRC) screening at age 45 years rather than 50 years, but little is known about screening completion and yield among people aged 45 to 49 years.</p><p><strong>Objective: </strong>To evaluate fecal immunochemical test (FIT) completion and yield in patients aged 45 to 49 versus 50 years.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>Kaiser Permanente Northern California, Washington, and Colorado.</p><p><strong>Patients: </strong>Those distributed a FIT kit during January to September 2022.</p><p><strong>Measurements: </strong>FIT completion within 3 months, FIT positivity, receipt of colonoscopy within 3 months after a positive FIT result, and colonoscopy yield.</p><p><strong>Results: </strong>A total of 267 732 FIT kits were distributed: 213 928 (79.9%) to patients aged 45 to 49 years, and 53 804 (20.1%) to those aged 50 years. Overall, FIT completion was slightly higher in patients aged 45 to 49 years (38.9% vs. 37.5%; adjusted risk ratio [aRR], 1.05 [95% CI, 1.04 to 1.06]), although at Colorado, those aged 45 to 49 years were substantially less likely to complete a FIT (30.7% vs. 40.2%; aRR, 0.77 [CI, 0.73 to 0.80]). Overall, FIT positivity was lower in patients aged 45 to 49 years (3.6% vs. 4.0%; aRR, 0.91 [CI, 0.84 to 0.98]), and receipt of colonoscopy after a positive FIT result was similar between groups (64.9% vs. 67.4%; aRR, 1.00 [CI, 0.94 to 1.05]). Adenoma detection was lower in the younger group (58.8% vs. 67.7%; aRR, 0.88 [CI, 0.83 to 0.95]). Yields were similar for adenoma with advanced histology (13.2% vs. 15.9%; aRR, 0.86 [CI, 0.69 to 1.07]), polyp with high-grade dysplasia (3.4% vs. 5.1%; aRR, 0.68 [CI, 0.44 to 1.04]), sessile serrated lesion (10.3% vs. 11.7%; aRR, 0.92 [CI, 0.71 to 1.21]), and CRC (2.8% vs. 2.7%; aRR, 1.10 [CI, 0.62 to 1.96]).</p><p><strong>Limitation: </strong>The small number of neoplasia events contributed to wide CIs.</p><p><strong>Conclusion: </strong>Similar FIT completion and yield rates in people aged 45 to 50 years support initiation of CRC screening at age 45 years.</p><p><strong>Primary funding source: </strong>Kaiser Permanente Sidney R. Garfield Memorial Fund.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":19.6000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7326/M24-0743","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Guidelines now recommend initiating colorectal cancer (CRC) screening at age 45 years rather than 50 years, but little is known about screening completion and yield among people aged 45 to 49 years.
Objective: To evaluate fecal immunochemical test (FIT) completion and yield in patients aged 45 to 49 versus 50 years.
Design: Retrospective cohort study.
Setting: Kaiser Permanente Northern California, Washington, and Colorado.
Patients: Those distributed a FIT kit during January to September 2022.
Measurements: FIT completion within 3 months, FIT positivity, receipt of colonoscopy within 3 months after a positive FIT result, and colonoscopy yield.
Results: A total of 267 732 FIT kits were distributed: 213 928 (79.9%) to patients aged 45 to 49 years, and 53 804 (20.1%) to those aged 50 years. Overall, FIT completion was slightly higher in patients aged 45 to 49 years (38.9% vs. 37.5%; adjusted risk ratio [aRR], 1.05 [95% CI, 1.04 to 1.06]), although at Colorado, those aged 45 to 49 years were substantially less likely to complete a FIT (30.7% vs. 40.2%; aRR, 0.77 [CI, 0.73 to 0.80]). Overall, FIT positivity was lower in patients aged 45 to 49 years (3.6% vs. 4.0%; aRR, 0.91 [CI, 0.84 to 0.98]), and receipt of colonoscopy after a positive FIT result was similar between groups (64.9% vs. 67.4%; aRR, 1.00 [CI, 0.94 to 1.05]). Adenoma detection was lower in the younger group (58.8% vs. 67.7%; aRR, 0.88 [CI, 0.83 to 0.95]). Yields were similar for adenoma with advanced histology (13.2% vs. 15.9%; aRR, 0.86 [CI, 0.69 to 1.07]), polyp with high-grade dysplasia (3.4% vs. 5.1%; aRR, 0.68 [CI, 0.44 to 1.04]), sessile serrated lesion (10.3% vs. 11.7%; aRR, 0.92 [CI, 0.71 to 1.21]), and CRC (2.8% vs. 2.7%; aRR, 1.10 [CI, 0.62 to 1.96]).
Limitation: The small number of neoplasia events contributed to wide CIs.
Conclusion: Similar FIT completion and yield rates in people aged 45 to 50 years support initiation of CRC screening at age 45 years.
Primary funding source: Kaiser Permanente Sidney R. Garfield Memorial Fund.
期刊介绍:
Established in 1927 by the American College of Physicians (ACP), Annals of Internal Medicine is the premier internal medicine journal. Annals of Internal Medicine’s mission is to promote excellence in medicine, enable physicians and other health care professionals to be well informed members of the medical community and society, advance standards in the conduct and reporting of medical research, and contribute to improving the health of people worldwide. To achieve this mission, the journal publishes a wide variety of original research, review articles, practice guidelines, and commentary relevant to clinical practice, health care delivery, public health, health care policy, medical education, ethics, and research methodology. In addition, the journal publishes personal narratives that convey the feeling and the art of medicine.